title: Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.
authors.affiliation: Division of Radiopharmacy, Paul Scherrer Institute, Villigen/PSI, Switzerland.
authors.forename: P A
authors.initials: PA
authors.lastname: Schubiger
authors.forename: R
authors.initials: R
authors.lastname: Alberto
authors.forename: A
authors.initials: A
authors.lastname: Smith
mesh_terms: D000906:Antibodies / Q000627:therapeutic use; D002614:Chelating Agents; D005818:Genetic Engineering; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D015394:Molecular Structure; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use*
chemical_list: D000906:Antibodies; D002614:Chelating Agents; D018796:Immunoconjugates; D011868:Radioisotopes